Clinical Trials
33 trialsTraveraRTGx
Travera Inc
Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
PMCF Study of the CE-marked Drainova® ArgentiC Catheter
ewimed GmbH
BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
Dana-Farber Cancer Institute
CEUS
The Children's Hospital of Zhejiang University School of Medicine
IPIZA
Qilu Hospital of Shandong University
SOMAPROTECT01
Hospices Civils de Lyon
KTMBO-RCT
National Taiwan University Hospital
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies
New Mexico Cancer Research Alliance
Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
High Definition Profiling of Ovarian Cancer Ascites
European Institute of Oncology
iMETABO
British Columbia Cancer Agency
Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites
Zhejiang Cancer Hospital
Symptomatic Ascites Drainage With a Patient-controlled Vascular Catheter.
Gdynia Oncology Center
Immune Checkpoints in Intraabdominal Ascites Fluid
Istanbul Training and Research Hospital
ROLLON
Post Graduate Institute of Medical Education and Research, Chandigarh
T Helper Cytokines in End Stage Colorectal Cancers
Istanbul Training and Research Hospital
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
Sun Yat-sen University
2011-AAR-004
Sequana Medical N.V.
Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
The First Affiliated Hospital with Nanjing Medical University
Long-term Follow-up of HALT-C Sustained Virological Responders
National Institutes of Health Clinical Center (CC)
PIPACRegis
University of Magdeburg
Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
National Institutes of Health Clinical Center (CC)
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Neovii Biotech
AGASA-SP
Institut Paoli-Calmettes
OTMA-RII
Galenic Research Institute Ltd
AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites
National Institutes of Health Clinical Center (CC)
Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer
Gdynia Oncology Center
The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites
National University Hospital, Singapore
Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural Effusion
Huazhong University of Science and Technology
Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites
Sanofi
B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites
University of Sao Paulo
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)